Child and Adolescent Health From 1990 to 2015 Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study

Carregando...
Imagem de Miniatura
Citações na Scopus
281
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
KASSEBAUM, Nicholas
KYU, Hmwe Hmwe
ZOECKLER, Leo
OLSEN, Helen Elizabeth
THOMAS, Katie
PINHO, Christine
BHUTTA, Zulfiqar A.
DANDONA, Lalit
FERRARI, Alize
GHIWOT, Tsegaye Tewelde
Citação
JAMA PEDIATRICS, v.171, n.6, p.573-592, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IMPORTANCE Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health. OBJECTIVE To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion. EVIDENCE REVIEW Cause-specific mortality and nonfatal health outcomes were analyzed for 195 countries and territories by age group, sex, and year from 1990 to 2015 using standardized approaches for data processing and statistical modeling, with subsequent analysis of the findings to describe levels and trends across geography and time among children and adolescents 19 years or younger. A composite indicator of income, education, and fertility was developed (Socio-demographic Index [SDI]) for each geographic unit and year, which evaluates the historical association between SDI and health loss. FINDINGS Global child and adolescent mortality decreased from 14.18 million (95% uncertainty interval [UI], 14.09 million to 14.28 million) deaths in 1990 to 7.26 million (95% UI, 7.14 million to 7.39 million) deaths in 2015, but progress has been unevenly distributed. Countries with a lower SDI had a larger proportion of mortality burden (75%) in 2015 than was the case in 1990 (61%). Most deaths in 2015 occurred in South Asia and sub-Saharan Africa. Global trends were driven by reductions in mortality owing to infectious, nutritional, and neonatal disorders, which in the aggregate led to a relative increase in the importance of noncommunicable diseases and injuries in explaining global disease burden. The absolute burden of disability in children and adolescents increased 4.3%(95% UI, 3.1%-5.6%) from 1990 to 2015, with much of the increase owing to population growth and improved survival for children and adolescents to older ages. Other than infectious conditions, many top causes of disability are associated with long-term sequelae of conditions present at birth (eg, neonatal disorders, congenital birth defects, and hemoglobinopathies) and complications of a variety of infections and nutritional deficiencies. Anemia, developmental intellectual disability, hearing loss, epilepsy, and vision loss are important contributors to childhood disability that can arise from multiple causes. Maternal and reproductive health remains a key cause of disease burden in adolescent females, especially in lower-SDI countries. In low-SDI countries, mortality is the primary driver of health loss for children and adolescents, whereas disability predominates in higher-SDI locations; the specific pattern of epidemiological transition varies across diseases and injuries. CONCLUSIONS AND RELEVANCE Consistent international attention and investment have led to sustained improvements in causes of health loss among children and adolescents in many countries, although progress has been uneven. The persistence of infectious diseases in some countries, coupled with ongoing epidemiologic transition to injuries and noncommunicable diseases, require all countries to carefully evaluate and implement appropriate strategies to maximize the health of their children and adolescents and for the international community to carefully consider which elements of child and adolescent health should be monitored.
Palavras-chave
Referências
  1. Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607
  2. Alkema L, 2011, DEMOGRAPHY, V48, P815, DOI 10.1007/s13524-011-0040-5
  3. Ashley MJ, 2016, TRAUMATIC BRAIN INJU
  4. Belli PC, 2003, EC BENEFITS INVESTIN
  5. Bol KA, 2006, PEDIATRICS, V117, P803, DOI 10.1542/peds.2005-1364
  6. Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092
  7. Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304
  8. Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714
  9. de Sousa A, 2012, B WORLD HEALTH ORGAN, V90, P183, DOI 10.2471/BLT.11.093989
  10. Department of Health Social Services and Public Safety, 2010, HLTH CHILD HLTH FUTU
  11. Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4
  12. Fajardo-Gutierrez A, 2016, SALUD PUBLICA MEXICO, V58, P162
  13. Fasfous A. F., 2013, J MUSLIM MENT HLTH, V7, P47, DOI [10.3998/jmmh.10381607.0007.203, DOI 10.3998/JMMH.10381607.0007.203]
  14. Fassa A G, 2000, Int J Occup Environ Health, V6, P55
  15. Field DJ, 2008, BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE
  16. Flaxman AD, 2014, INT MET FRAM DESCR E
  17. GBD 2015 SDG Collaborators, 2016, LANCET, V388, P1813
  18. Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164
  19. Gupta N, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-16
  20. Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898
  21. Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3
  22. Hillner BE, 2000, J CLIN ONCOL, V18, P2327
  23. Hoofien D, 2001, BRAIN INJURY, V15, P189
  24. Huicho L, 2010, B WORLD HEALTH ORGAN, V88, P357, DOI 10.2471/BLT.09.070920
  25. Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X
  26. Institute for Health Metrics and Evaluation (IHME), 2015, FIN GLOB HLTH 2014 S
  27. Institute for Health Metrics and Evaluation (IHME), 2013, FIN GLOB HLTH 2012 E
  28. Italia Y, 2015, J MED SCREEN, V22, P1, DOI 10.1177/0969141314557372
  29. Jakovljevic M, 2016, HLTH EC POLICY CHALL, P1
  30. Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001
  31. Johnson P, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-42
  32. Kassebaum NJ, 2016, LANCET, V388, P1775
  33. Kassebaum NJ, 2016, LANCET, V388, P1603
  34. Kellermann AL, 1998, ANNU REV PUBL HEALTH, V19, P271, DOI 10.1146/annurev.publhealth.19.1.271
  35. Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103
  36. Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276
  37. Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2
  38. Makene CL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0381-3
  39. McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068
  40. Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
  41. Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6
  42. Papile LA, 2012, PEDIATRICS, V130, P587, DOI 10.1542/peds.2012-1999
  43. Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1
  44. Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66
  45. Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109
  46. SALOMON JA, 2013, LANCET, V381, P628
  47. Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
  48. Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
  49. Scott JG, 2016, MENTAL NEUROLOGICAL, V4
  50. Shaw PH, 2015, J PEDIAT HEMATOL ONC, V37, P161, DOI 10.1097/MPH.0000000000000318
  51. SLOAN JH, 1990, NEW ENGL J MED, V322, P369, DOI 10.1056/NEJM199002083220605
  52. Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67
  53. Stevens GA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002056
  54. Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X
  55. The United Nations, 1989, CONV RIGHTS CHILD, V1577, P3
  56. United Nations (UN), 2015, MILL DEV GOALS 2015
  57. Ursin M., 2014, CONTEMP DRUG PROBL, V41, P171, DOI [10.1177/009145091404100203, DOI 10.1177/009145091404100203]
  58. Vos T, 2016, LANCET, V388, P1545
  59. Wang HD, 2016, LANCET, V388, P1725
  60. Wang HD, 2016, LANCET, V388, P1459
  61. Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X
  62. World Health Organization, 2013, DEF KEY TERMS
  63. World Health Organization, GLOB STRAT WOM CHILD
  64. Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438
  65. Yuko-Jowi Christine Awuor, 2012, Cardiovasc Diagn Ther, V2, P231, DOI 10.3978/j.issn.2223-3652.2012.07.04
  66. Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93
  67. Zuhlke L, 2013, HEART, V99, P1554, DOI 10.1136/heartjnl-2013-303896